Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serum Ferritin in Diagnosis and Prognosis of irAEs
NCT06702566Recruiting
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Start
- Jul 2024
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Open-label trial (3 arms), sponsored by Tianjin Medical University Cancer Institute and Hospital. Primary endpoints: Calculated cut-off value for serum ferritin in the diagnosis of irAE at 1 year, Sensitivity and specificity of serum ferritin in the diagnosis of irAE at 1 year and 1 more. Started Jul 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06702566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06702566.